Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 68071-2876 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 2876 9

pdp - 68071 2876 9

This is a description of a medication called Gabapentin 300mg contained in a bottle with Lot: 00000 and NDC number: 68071-2876-09. The bottle contains 90 capsules that are oblong, yellow with an opaque body and cap, and each capsule is imprinted with 'AHD' on the cap and 300-ZRD on the body. The medication should be stored at a controlled temperature of 68-77°F and kept out of reach of children. In case of side effects, patients should contact their doctor or the FDA.*

formula - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

formula - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

This appears to be a formula for calculating creatinine clearance (ClCr) in patients, which is a measure of kidney function. It takes into account the patient's age, weight, and serum creatinine levels. The formula includes a correction factor for female patients.*

figure1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

figure1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

image 1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

image 1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

image 2 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

image 2 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

This appears to be a table showing the pain scores for a 4-week fixed dose period study with two different doses of Gabapentin and a placebo. There are seven time points labeled as Baseline, 1 through 7. There is not enough information to provide further details or context.*

image 3 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

image 3 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

The text is describing the proportion of responders (patients with a reduction in pain score) in controlled PHN studies. It includes figures for two studies (study 1 and study 2) and information on the cost of GBP 3600 for the study drug, GBP 1800 for a placebo, and GBP 2400 for an unspecified option. There are also some statistical symbols, but the meaning is unclear without further context.*

image 4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

image 4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.